fda approved glp-1 agonists New Pill Foundayo (Orforglipron) Gets Approval for Obesity 💊New GLP-1 pill gets FDA

Researchers at Massachusetts Eye and Ear, a Harvard-associated specialty hospital in Boston, found that individuals who took Ozempic were at a significantly higher risk of developing Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a condition that can lead to sudden vision loss

J Neuroimmunol (2018) 316:1722

And the small number of patients an average of about 100 cases were identified each year from one specialized medical center may not apply to a broader population

Department of Psychiatry, University of Toronto, Toronto, ON, M5T1R8, Canada

GLP-1 drugs for weight loss typically involve higher dosages than the same drug taken to manage diabetes

The effect on heart failure must be regarded as preventive rather than curative, since dedicated trials revealed no effect on any parameter associated with heart failure [23]